Trimetazidine Instable Angina Pectoris and Type 2 Diabetes Mellitus: Safety & Effectiveness: A Descriptive Study

Journal of Medical Science And clinical Research
doi 10.18535/jmscr/v7i12.112
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Valley International

Related search

Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus

Cureus
2017English

Prognostic Significance of Proinflammatory Factors in Patients With Progressive Angina Pectoris and Type 2diabetes Mellitus

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Angina Pectoris.

BMJ
1971English

Effectiveness and Safety of Laparoscopic Roux-En-Y Gastric Bypass for the Treatment of Type 2 Diabetes Mellitus

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

Angina Pectoris

Postgraduate Medical Journal
Medicine
1929English

A Study of Cognitive Dysfunctions in Type 2 Diabetes Mellitus

Journal of Evolution of Medical and Dental Sciences
2019English

Obesity and Type 2 Diabetes Mellitus

Internal Medicine: Open Access
2014English

Obesity and Type 2 Diabetes Mellitus

Integrative Obesity and Diabetes
2018English

Clinical Acceptability of Trimetazidine Modified-Release 80 Mg Once Daily Versus Trimetazidine Modified-Release 35 Mg Twice Daily in Stable Angina Pectoris

Cardiology and Therapy
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy